Overview
Joseph Dibenedetto is a Hematologist Oncology provider in Providence, Rhode Island. His top areas of expertise are Myeloproliferative Neoplasms (MPN) and Hemochromatosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
Rhode Island Hospital
Adam Olszewski is a Hematologist Oncology specialist and a Hematologist in Providence, Rhode Island. Dr. Olszewski is highly rated in 26 conditions, according to our data. His top areas of expertise are B-Cell Lymphoma, Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, Splenectomy, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute, Inc.
Paul Richardson is a Hematologist Oncology specialist and an Oncologist in Milford, Massachusetts. Dr. Richardson is highly rated in 18 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Hepatic Venoocclusive Disease with Immunodeficiency, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Graft. Dr. Richardson is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
David Reardon is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Reardon is highly rated in 22 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HemochromatosisDr. Dibenedetto isExperienced. Learn about Hemochromatosis.
- Myeloproliferative Neoplasms (MPN)Dr. Dibenedetto isExperienced. Learn about Myeloproliferative Neoplasms (MPN).